Business
ERMA: US pouch sales drove revenue growth and improved liquidity, with narrowed losses
ERMA: US pouch sales drove revenue growth and improved liquidity, with narrowed losses
About this update from Enorama Pharma Ab
Net sales surged year-over-year, driven by US pouch sales, while losses narrowed and liquidity improved. Strategic focus is on US expansion, increased production capacity, and regulatory progress for nicotine pouches.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.